---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-030375"
form_type: "8-K"
ticker: "OSTX"
cik: "0001795091"
company_name: "OS Therapies Inc"
filed_at: "2025-04-09T23:59:59+00:00"
generated_at: "2026-05-23T18:32:02.447635+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve issuance of shares exceeding 20% of outstanding common stock

## Summary
- Special meeting held April 9, 2025; proposal passed with 11,587,018 votes in favor (99.3% of votes cast).
- Approval covers conversion of 1,775,750 Series A Preferred shares and exercise of warrants from private placement.
- Issuance without regard to conversion/exercise limits can dilute existing holders by at least 20%.

## SEC filing metadata
- accession: 0001213900-25-030375
- form_type: 8-K
- ticker: OSTX
- cik: 0001795091
- company_name: OS Therapies Inc
- filed_at: 2025-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1795091/000121390025030375/0001213900-25-030375-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1795091/000121390025030375/ea0237768-8k_ostherapies.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-030375
- JSON: https://secwatch.observer/filing/0001213900-25-030375.json
- Plain text: https://secwatch.observer/filing/0001213900-25-030375.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.